
### [MONDO:0005917](http://purl.obolibrary.org/obo/MONDO_0005917)
**Label:** placenta disease

**Subclasses:** [MONDO:0016786](http://purl.obolibrary.org/obo/MONDO_0016786) (partial hydatidiform mole), [MONDO:0016785](http://purl.obolibrary.org/obo/MONDO_0016785) (complete hydatidiform mole), [MONDO:0020549](http://purl.obolibrary.org/obo/MONDO_0020549) (invasive hydatidiform mole), [MONDO:0009273](http://purl.obolibrary.org/obo/MONDO_0009273) (hydatidiform mole, recurrent, 1), [MONDO:0000409](http://purl.obolibrary.org/obo/MONDO_0000409) (chorioamnionitis), [MONDO:0005919](http://purl.obolibrary.org/obo/MONDO_0005919) (placental insufficiency), [MONDO:0013671](http://purl.obolibrary.org/obo/MONDO_0013671) (hydatidiform mole, recurrent, 2), [MONDO:0005918](http://purl.obolibrary.org/obo/MONDO_0005918) (placenta praevia), [MONDO:0021498](http://purl.obolibrary.org/obo/MONDO_0021498) (benign neoplasm of placenta), [MONDO:0001558](http://purl.obolibrary.org/obo/MONDO_0001558) (Potter's syndrome), [MONDO:0005916](http://purl.obolibrary.org/obo/MONDO_0005916) (placenta accreta), [MONDO:0004846](http://purl.obolibrary.org/obo/MONDO_0004846) (placental abruption (disease)), [MONDO:0021218](http://purl.obolibrary.org/obo/MONDO_0021218) (placenta neoplasm), [MONDO:0002178](http://purl.obolibrary.org/obo/MONDO_0002178) (placenta cancer), [MONDO:0006248](http://purl.obolibrary.org/obo/MONDO_0006248) (hydatidiform mole), [MONDO:0004585](http://purl.obolibrary.org/obo/MONDO_0004585) (polyhydramnios (disease)), [MONDO:0002077](http://purl.obolibrary.org/obo/MONDO_0002077) (low implantation of placenta), [MONDO:0005881](http://purl.obolibrary.org/obo/MONDO_0005881) (oligohydramnios (disease)), [MONDO:0006375](http://purl.obolibrary.org/obo/MONDO_0006375) (placental hemangioma), [MONDO:0006374](http://purl.obolibrary.org/obo/MONDO_0006374) (placental choriocarcinoma), [MONDO:0005030](http://purl.obolibrary.org/obo/MONDO_0005030) (fetal growth restriction), 

**Mapped go classes:** [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding), 

**Class expressions from DL-Learner:**

- [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding) 60.00%
- [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity) 60.00%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 60.00%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 60.00%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%


